drug · small molecule
milrinone ER
Phase 2updated 3mo agoby Hyloris Pharmaceuticals SA🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for congestive heart failure and cardiovascular disease and 8 investigational indications.
targets
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A
all catalysts(0)
nothing on the calendar yet
Trials studying milrinone ER
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that